Previous Close | 26.23 |
Open | 26.14 |
Bid | 23.37 x 100 |
Ask | 23.48 x 100 |
Day's Range | 23.23 - 26.14 |
52 Week Range | 13.36 - 27.50 |
Volume | |
Avg. Volume | 362,647 |
Market Cap | 701.996M |
Beta (5Y Monthly) | -0.31 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
AnaptysBio (ANAB) delivered earnings and revenue surprises of -6.49% and 57.78%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
AnaptysBio (ANAB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AnaptysBio (ANAB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.